☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Alnylam Presents 18-Month Results in the P-III (HELIOS-A) Study of Vutrisiran for hATTR Amyloidosis with Polyneuropathy at ESC 202...
May 23, 2022
Merck Receives CHMP Positive Opinion of Keytruda (pembrolizumab) as Adjuvant Treatment for Stage IIB or IIC Melanoma
May 23, 2022
13th Summit on Biosimilars & Innovator Biologics
May 23, 2022
PharmaShots Interview: Indapta’s Mark Frohlich Shares Insights on the $50M Series A Financing
May 23, 2022
Regeneron Presents Results of Evkeeza (evinacumab) in P-III Trial for Homozygous Familial Hypercholesterolemia in Children at EAS...
May 23, 2022
Kala Entered into Definitive Agreement with Alcon to Acquire Eysuvis and Inveltys for the Treatment of Acute Dry Eye Disease
May 23, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions